Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 5/20 | 0.56 |
| ▸ | ITGA2B | P08514 | 5/20 | 0.56 |
| ▸ | LTA4H | P09960 | 4/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.45 |
| ▸ | PPARA | Q07869 | 3/20 | 0.45 |
| ▸ | PPARG | P37231 | 2/20 | 0.45 |
| ▸ | PTGES | O14684 | 1/20 | 0.45 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.45 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.44 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.44 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.44 |
| ▸ | PPARD | Q03181 | 2/20 | 0.43 |
| ▸ | CPA3 | P15088 | 1/20 | 0.42 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16387433 | 1.00 | ITGB3 (0.56) | ITGB3ITGA2BLTA4HPTPN1PPARA | |
| SCHEMBL16387611 | 1.00 | ITGB3 (0.56) | ITGB3ITGA2BLTA4HPTPN1PPARA | |
| SCHEMBL13571275 | 1.00 | ITGB3 (0.56) | ITGB3ITGA2BLTA4HPTPN1PPARA | |
| SCHEMBL16343355 | 1.00 | ITGB3 (0.56) | ITGB3ITGA2BLTA4HPTPN1PPARA | |
| SCHEMBL16387425 | 1.00 | ITGB3 (0.56) | ITGB3ITGA2BLTA4HPTPN1PPARA | |
| SCHEMBL16387432 | 1.00 | ITGB3 (0.56) | ITGB3ITGA2BLTA4HPTPN1PPARA | |
| SCHEMBL13570877 | 1.00 | ITGB3 (0.56) | ITGB3ITGA2BLTA4HPTPN1PPARA | |
| SCHEMBL13571111 | 1.00 | ITGB3 (0.56) | ITGB3ITGA2BLTA4HPTPN1PPARA | |
| SCHEMBL16344110 | 1.00 | ITGB3 (0.56) | ITGB3ITGA2BLTA4HPTPN1PPARA | |
| SCHEMBL16387452 | 0.91 | ITGB3 (0.53) | ITGB3ITGA2BPTPN1PPARAPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9238631-B2 | Radiolabeled amino acids for diagnostic imaging | PIRAMAL IMAGING SA (CH) | 2016-01-19 | — | — | US | disclosed |
| US-20150011773-A1 | RADIOLABELED AMINO ACIDS FOR DIAGNOSTIC IMAGING | PIRAMAL IMAGING SA (CH) | 2015-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150011773-A1 | RADIOLABELED AMINO ACIDS FOR DIAGNOSTIC IMAGING | SLC1A5, SLC6A19, BCAT2 | ITGB3 1794/4885ITGA2B 2819/4885LTA4H 2793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.